West Pharmaceutical Services Shares Are Trading Higher After UBS Upgraded the Stock From Neutral to Buy and Raised Its Price Target From $350 to $390.
West Pharmaceutical Services Shares Are Trading Higher After UBS Upgraded the Stock From Neutral to Buy and Raised Its Price Target From $350 to $390.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.